IDYA
IDEAYA Biosciences·NASDAQ
--
--(--)
--
--(--)
8.29 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: four analysts issue Strong Buy or Buy with 100% win rates. Fund‑flow rating is good (7.85), showing positive inflows across all block sizes. Combined, they reinforce a strong upside bias.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-18
InstitutionRBC Capital
Times predicted5
Historical Win Rate80.0%
What is the analyst consensus for IDYA?
- IDYA holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.29/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
